Aperio Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $218K | Sell |
12,235
-1,496
| -11% | -$26.7K | ﹤0.01% | 2287 |
|
|
2020
Q3 | $203K | Sell |
13,731
-2,837
| -17% | -$41.9K | ﹤0.01% | 2229 |
|
|
2020
Q2 | $348K | Sell |
16,568
-1,933
| -10% | -$40.6K | ﹤0.01% | 1958 |
|
|
2020
Q1 | $428K | Buy |
18,501
+2,738
| +17% | +$63.3K | ﹤0.01% | 1732 |
|
|
2019
Q4 | $408K | Sell |
15,763
-1,874
| -11% | -$48.5K | ﹤0.01% | 1918 |
|
|
2019
Q3 | $343K | Buy |
17,637
+6,705
| +61% | +$130K | ﹤0.01% | 1959 |
|
|
2019
Q2 | $178K | Sell |
10,932
-1,132
| -9% | -$18.4K | ﹤0.01% | 2216 |
|
|
2019
Q1 | $274K | Buy |
12,064
+3,652
| +43% | +$82.9K | ﹤0.01% | 2048 |
|
|
2018
Q4 | $215K | Buy |
8,412
+2,255
| +37% | +$57.6K | ﹤0.01% | 2094 |
|
|
2018
Q3 | $201K | Buy |
+6,157
| New | +$201K | ﹤0.01% | 2191 |
|
|
2017
Q3 | – | Sell |
-5,144
| Closed | -$205K | – | 2237 |
|
|
2017
Q2 | $205K | Buy |
+5,144
| New | +$205K | ﹤0.01% | 2089 |
|